Skip to main content
Clinical Trials/CTRI/2024/06/069573
CTRI/2024/06/069573
Not yet recruiting
Phase 4

A Study to compare the efficacy and safety of subcostal transverse abdominis plane block versus external oblique intercostal plane block as a part of multimodal analgesia among patients undergoing upper abdominal surgeries -A single blind , randomised control trial

Dr Priyanka D S1 site in 1 country50 target enrollmentStarted: July 20, 2024Last updated:

Overview

Phase
Phase 4
Status
Not yet recruiting
Sponsor
Dr Priyanka D S
Enrollment
50
Locations
1
Primary Endpoint
1.Duration of post operative analgesia

Overview

Brief Summary

50 patients of ASA grade 1 and 2 undergoing upper abdominal surgeries under general anaesthesia are randomly allocated into 2 groups.

Group S - 25 patients  receiving subcostal transverse abdominis plane block

Group E- 25 patients receiving External oblique intercostal plane block

After induction of general anesthesia, patient in supine position, under asepsis and under ultrasound guidance sono anatomy identified and block given with inj bupivacaine 0.25% 20 ml  each side after negative aspiration for blood .after completion of surgery , inhalational agents discontinued, 100 % oxygen given , neuromuscular agents reversed  with glyco pyrolate and neostigmine. Extubation done once patient has met extubation criteria is met..

Post operative hemodynamic monitoring , assessment of pain using VAS Scores , first rescue analgesia and total analgesic requirement in 24 hours is assessed.. data analysis done by descriptive statistics.

Study Design

Study Type
Interventional
Allocation
Randomized
Masking
Participant and Outcome Assessor Blinded

Eligibility Criteria

Ages
18.00 Year(s) to 60.00 Year(s) (—)
Sex
All

Inclusion Criteria

  • 1.patient willing to give informed written consent 2.American society of anesthesiologist grade 1 and 2 , 3.scheduled to undergo elective upper abdominal surgeries under general anesthesia (epigastric herniotomy, gastrectomy,open cholecystectomy, gastric perforation repair).

Exclusion Criteria

  • Patient refusal to give informed written consent
  • Allergy to local anesthetics
  • Infection at the site of injection 4.coagulopathy.5.prolonged opioid medication 6.chronic liver disease, chronic renal disease and cognitive impairment.

Outcomes

Primary Outcomes

1.Duration of post operative analgesia

Time Frame: Immediate postoperative period, 2 hours, 6 hours 12 hours 24 hours

2.Time for requirement of first rescue analgesia

Time Frame: Immediate postoperative period, 2 hours, 6 hours 12 hours 24 hours

3.post operative pain scores(VAS Scores)

Time Frame: Immediate postoperative period, 2 hours, 6 hours 12 hours 24 hours

4. Total consumption of rescue analgesia in 24 hours

Time Frame: Immediate postoperative period, 2 hours, 6 hours 12 hours 24 hours

Secondary Outcomes

  • Hemodynamic monitoring

Investigators

Sponsor
Dr Priyanka D S
Sponsor Class
Other [self]
Responsible Party
Principal Investigator
Principal Investigator

Dr Priyanka D S

Bangalore medical college and research institute, Bangalore

Study Sites (1)

Loading locations...

Similar Trials